The June 21, 2022, session of Duke Medicine LEADS featured Teresa Tarrant, MD presenting on "Cytokine Signaling and Biologics in Atopic Disease."
- Targeted T helper 2 (Th2) biologic therapy is safe and effective for patients with atopic disease.
- In atopic patients where antihistamines and topical corticosteroids have failed and where allergen immunotherapy may not be feasible, therapeutic targeting of cytokine signaling pathways may provide substantial improvement in quality of life outcomes.
Duke Medicine Learning, Education, and Discussion Series (LEADS) takes place each Tuesday at 12 p.m. Learn more and see schedule of upcoming sessions.